Hiroko Oshima
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroko Oshima.
Cell | 1996
Masanobu Oshima; Joseph E. Dinchuk; Stacia Kargman; Hiroko Oshima; Bruno C. Hancock; Elizabeth Kwong; James M. Trzaskos; Jilly F. Evans; Makoto M. Taketo
Two cyclooxygenase isozymes catalyze conversion of arachidonic acid to prostaglandin H2: constitutive COX-1 and inducible COX-2. To assess the role of COX-2 in colorectal tumorigenisis, we determined the effects of COX-2 gene (Ptgs2) knockouts and a novel COX-2 inhibitor on Apc delta716 knockout mice, a model of human familial adenomatous polyposis. A Ptgs2 null mutation reduced the number and size of the intestinal polyps dramatically. Furthermore, treating Apc delta716 mice with a novel COX-2 inhibitor reduced the polyp number more significantly than with sulindac, which inhibits both isoenzymes. These results provide direct genetic evidence that COX-2 plays a key role in tumorigenesis and indicate that COX-2-selective inhibitors can be a novel class of therapeutic agents for colorectal polyposis and cancer.
Cancer Research | 2004
Naomoto Harada; Hiroko Oshima; Masahiro Katoh; Yositaka Tamai; Masanobu Oshima; Makoto M. Taketo
We have established previously a mouse strain containing a mutant β-catenin allele of which exon 3 was sandwiched by loxP sequences [Catnblox(ex3)]. In this mouse strain, a Wnt-activating β-catenin mutation alone is insufficient for hepatocarcinogenesis, but additional mutations or epigenetic changes may be required. Here we report that hepatocellular carcinoma develops at the 100% incidence in mice with simultaneous mutations in the β-catenin and H-ras genes that are introduced by adenovirus-mediated Cre expression. Although H-ras mutation alone rapidly causes large cell dysplasia in the hepatocytes, these cells show no autonomous growth within 1 week after infection of the Cre-adenovirus. However, simultaneous induction of an additional mutation in the β-catenin gene causes a clonal expansion of such dysplastic cells, followed by nodular formation and development of hepatocellular carcinoma. These results indicate that β-catenin mutations play a critical role in hepatocarcinogenesis in cooperation with another oncogene and that these mice provide a convenient model to investigate early steps of hepatocarcinogenesis.
Developmental Biology | 1996
Masanobu Oshima; Hiroko Oshima; Makoto M. Taketo
Cancer Research | 2002
Naomoto Harada; Hiroyuki Miyoshi; Naomi Murai; Hiroko Oshima; Yoshitaka Tamai; Masanobu Oshima; Makoto M. Taketo
Carcinogenesis | 1995
Masanobu Oshima; Mami Takahashi; Hiroko Oshima; Masahiro Tsutsumi; Kazunaga Yazawa; Takashi Sugimura; Susumu Nishimura; Keiji Wakabayashi; Makoto M. Taketo
The Japanese Biochemical Society/The Molecular Biology Society of Japan | 2017
Nobuyuki Fujiwara; Syusaku Shibutani; Yusuke Sakai; Hiroshi Shima; Toshio Watanabe; Hiroko Oshima; Masanobu Oshima; Tatsuya Saitoh; Shizuo Akira; Hiroaki Nagano; Tathuya Usui; Takashi Ohama; Koichi Sato
Cancer Research Institution Report = がん研究所年報 | 2009
Hiroko Oshima; Masanobu Oshima
Cancer Research Institution Report = がん研究所年報 | 2009
Hiroko Oshima; Masanobu Oshima
Cancer Research Institution Report = がん研究所年報 | 2009
Keisuke Oguma; Hiroko Oshima; Masanobu Oshima
Archive | 2008
Keisuke Oguma; Hiroko Oshima; Masahiro Aoki; Ryusei Uchio; Satoshi Nakamura; Atsushi Hirao; Hideyuki Saya; Makoto M. Taketo; Masanobu Oshima